Sterile hyaluronic acid solutions
AssigneeBausch & Lomb Incorporated
InventorsX. Michael Liu, David J. Heiler, Thomas Menzel, Abbie Brongo, Susan E. Burke, Karl Cummins
Life of this patent
Estimating the term…
Loading patent…
AssigneeBausch & Lomb Incorporated
InventorsX. Michael Liu, David J. Heiler, Thomas Menzel, Abbie Brongo, Susan E. Burke, Karl Cummins
Estimating the term…
A process for sterilizing a solution comprising hyaluronic acid. The process comprises providing an aqueous solution of hyaluronic acid with a weight average molecular weight from 0.6 MDa to 3.6 MDa, and the concentration of the hyaluronic acid is from 0.04% to 0.8% by weight. The aqueous solution also has an ionic strength equivalent to an aqueous concentration of sodium chloride from 3% to 30% by weight. Once the aqueous, high salt, hyaluronic acid solution is prepared the solution is maintained at a temperature from 40° C. to 80° C. for at least 1 hour and not longer than six days. Following the heat treatment step, the aqueous solution is filtered through a sterilization filter medium to provide a sterilized high salt, hyaluronic acid solution.
A process for sterilizing a solution, the process comprising:
A process for sterilizing a solution comprising hyaluronic acid, the process comprising:
A process of preparing a production batch of a contact lens care solution, the process comprising:
Dependencies are inferred from the claim text.